-
Product Insights
Likelihood of Approval Analysis for Posterior Uveitis
Overview How likely is it that the drugs in Posterior Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Posterior Uveitis Overview Posterior uveitis refers to intraocular inflammation in the vitreous,...
-
Sector Analysis
Ophthalmic Viscoelastic Devices (OVD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Ophthalmic Viscoelastic Devices (OVD) Market Report Overview The ophthalmic viscoelastic devices (OVD) market size was $1.2 billion in 2023. The market will grow at a CAGR of more than 2% during 2023-2033. Ophthalmic viscoelastic devices, also known as OVDs, are devices used during intraocular surgery, especially anterior segment surgery. These are the viscoelastic materials used to maintain space in the eye during surgery. Typically, OVDs are pre-packaged in a syringe and are applied using a small tube. Essential properties of...
-
Product Insights
Likelihood of Approval Analysis for Choroidal Neovascularization
Overview How likely is it that the drugs in Choroidal Neovascularization will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Choroidal Neovascularization Overview Choroidal neovascularization (CNV) involves the growth of new blood...
-
Product Insights
Likelihood of Approval Analysis for Sickle Cell Disease
Overview How likely is it that the drugs in Sickle Cell Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sickle Cell Disease Overview Sickle cell anemia is a genetic (inherited)...
-
Product Insights
Likelihood of Approval Analysis for Leber Congenital Amaurosis (LCA)
Overview How likely is it that the drugs in Leber Congenital Amaurosis (LCA) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leber Congenital Amaurosis (LCA) Overview Leber congenital amaurosis (LCA) is...
-
Product Insights
Likelihood of Approval Analysis for Non-infectious Uveitis
Overview How likely is it that the drugs in Non-infectious Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Non-infectious Uveitis Overview Non-infectious uveitis (NIU) is a group of disorders characterized...
-
Product Insights
Likelihood of Approval Analysis for Retinal Vein Occlusion
Overview How likely is it that the drugs in Retinal Vein Occlusion will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinal Vein Occlusion Overview Retinal vein occlusion is a blockage in...
-
Product Insights
Likelihood of Approval Analysis for Retinopathy
Overview How likely is it that the drugs in Retinopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinopathy Overview Retinopathy is any damage to the retina of the eyes, which...
-
Product Insights
Likelihood of Approval Analysis for Neuromyelitis Optica (Devic’s Syndrome)
Overview How likely is it that the drugs in Neuromyelitis Optica (Devic's Syndrome) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neuromyelitis Optica (Devic's Syndrome) Overview Neuromyelitis optica (NMO), also known...
-
Product Insights
Likelihood of Approval Analysis for Glaucoma
Overview How likely is it that the drugs in Glaucoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Glaucoma Overview Glaucoma is a disease of the eye in which fluid pressure...